SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001387131-17-002197
Filing Date
2017-04-21
Accepted
2017-04-21 13:34:06
Documents
4
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT admp-s3mef_041717.htm S-3MEF 57268
2 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN, LAW CORPORATION ex5-1.htm EX-5.1 7427
3 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-1.htm EX-23.1 3308
4 CONSENT OF HUDSON, CISNE & CO. LLP. ex23-2.htm EX-23.2 3420
  Complete submission text file 0001387131-17-002197.txt   72580
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-217408 | Film No.: 17775119
SIC: 2834 Pharmaceutical Preparations